Halozyme Therapeutics Inc. buy Benchmark Co.
Start price
20.02.25
/
50%
€54.68
Target price
20.02.26
€71.72
Performance (%)
18.36%
Price
23:26
€64.72
Summary
This prediction is currently active. The BUY prediction by Benchmark_Co_ currently has a performance of 18.36%. This prediction currently runs until 20.02.26. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Halozyme Therapeutics Inc. | 7.381% | 7.381% |
| iShares Core DAX® | -0.436% | 1.181% |
| iShares Nasdaq 100 | 0.854% | 1.475% |
| iShares Nikkei 225® | 2.652% | 6.401% |
| iShares S&P 500 | 1.190% | 1.169% |
Comments by Benchmark_Co_ for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $75.00 price target on the stock.
Ratings data for HALO provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€66.40
24.09.25
24.09.25
€76.27
24.09.26
24.09.26
-2.53%
23:26
23:26
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.87
08.08.24
08.08.24
€55.00
08.08.25
08.08.25
10.25%
09.08.25
09.08.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.68
25.06.24
25.06.24
€56.00
25.06.25
25.06.25
-7.99%
26.06.25
26.06.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.23
16.04.24
16.04.24
€46.98
16.04.25
16.04.25
43.42%
17.04.25
17.04.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.35
19.01.24
19.01.24
€45.94
19.01.25
19.01.25
69.19%
20.01.25
20.01.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.23
20.10.23
20.10.23
€47.17
20.10.24
20.10.24
45.44%
21.10.24
21.10.24